Pacira Pharmaceuticals (PCRX) Earnings
|
Expand Research on PCRX
| Next EPS Date | 8/5/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -5.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/26  |
Q126 | N/A | $0.73 | N/A | N/A | $186.54M | = | N/A | N/A | ||
| 2/26/26 | Q425 | $0.57 | $0.90 | -$0.33 | $196.9M | $200.54M | = |  | | Details | |
| 11/6/25 | Q325 | $0.70 | $0.65 | +$0.05 | $179.5M | $182.29M | = | | | Details | |
| 10/30/25 |
Q325 | N/A | $0.65 | N/A | N/A | $182.29M | = | N/A | N/A | ||
| 8/5/25 | Q225 | $0.74 | $0.72 | +$0.02 | $180.35M | $184.32M | = | | | Details | |
| 5/8/25 | Q125 | $0.62 | $0.59 | +$0.03 | $168.92M | $175.6M | = | | | Details | |
| 4/30/25 |
Q125 | N/A | $0.59 | N/A | N/A | $175.6M | = | N/A | N/A | ||
| 2/27/25 | Q424 | $0.91 | $0.79 | +$0.12 | $187.3M | $180.22M | = | | | Details |
